A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT® Re-usable in the Nordics and Benelux
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT® Re-usable in the Nordics and Benelux
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume 36, Issue 12, Pages 3435-3445
Publisher
Springer Science and Business Media LLC
Online
2019-10-17
DOI
10.1007/s12325-019-01114-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler
- (2019) Rajiv Dhand et al. International Journal of Chronic Obstructive Pulmonary Disease
- Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France
- (2019) Christos Chouaid et al. CURRENT MEDICAL RESEARCH AND OPINION
- Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications
- (2019) Holly McCabe et al. Expert Review of Respiratory Medicine
- ENVIRONMENTAL IMPACT ASSESSMENT OF A HEALTH TECHNOLOGY: A SCOPING REVIEW
- (2018) Julie Polisena et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Value Assessment at the Point of Care: Incorporating Patient Values throughout Care Delivery and a Draft Taxonomy of Patient Values
- (2017) Melissa J. Armstrong et al. VALUE IN HEALTH
- Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions
- (2017) Mark Sculpher et al. VALUE IN HEALTH
- Advancing Value Assessment in the United States: A Multistakeholder Perspective
- (2017) Corinna Sorenson et al. VALUE IN HEALTH
- Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes
- (2017) Rob Baltussen et al. VALUE IN HEALTH
- Evaluating Frameworks That Provide Value Measures for Health Care Interventions
- (2017) Jeanne S. Mandelblatt et al. VALUE IN HEALTH
- Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis
- (2017) Louis P. Garrison et al. VALUE IN HEALTH
- Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment
- (2017) Natalia Hawken et al. BMC Pulmonary Medicine
- Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices
- (2016) Federico Lavorini et al. DRUGS & AGING
- INCORPORATING ENVIRONMENTAL OUTCOMES INTO A HEALTH ECONOMIC MODEL
- (2016) Kevin Marsh et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses
- (2016) Gillian D. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Expanding Health Technology Assessments to Include Effects on the Environment
- (2016) Kevin Marsh et al. VALUE IN HEALTH
- Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler®
- (2016) P.N. Richard Dekhuijzen et al. Patient Preference and Adherence
- Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR)
- (2015) Federico Lavorini et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Switching from branded to generic inhaled medications: potential impact on asthma and COPD
- (2013) Federico Lavorini et al. Expert Opinion on Drug Delivery
- Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force
- (2013) Sean D. Sullivan et al. VALUE IN HEALTH
- Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat® Soft Mist™ Inhaler
- (2012) Rick Hodder International Journal of Chronic Obstructive Pulmonary Disease
- Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma
- (2012) Toby GD Capstick et al. Expert Review of Respiratory Medicine
- COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population
- (2011) Monica J Fletcher et al. BMC PUBLIC HEALTH
- Costing and Perspective in Published Cost-Effectiveness Analysis
- (2009) Peter J. Neumann MEDICAL CARE
- The ADMIT series — Issues in Inhalation Therapy. 4) How to choose inhaler devices for the treatment of COPD
- (2009) Walter Vincken et al. Primary Care Respiratory Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More